Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

467 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Distribution of esophageal inflammation in patients with eosinophilic esophagitis and its impact on diagnosis and outcome.
Sorge A, Aldinio G, Marinoni B, Visaggi P, Penagini R, Maniero D, Ghisa M, Marabotto E, de Bortoli N, Pasta A, Dipace V, Calabrese F, Vecchi M, Savarino EV, Coletta M. Sorge A, et al. Among authors: coletta m. Dig Liver Dis. 2025 Jan;57(1):260-265. doi: 10.1016/j.dld.2024.08.049. Epub 2024 Sep 13. Dig Liver Dis. 2025. PMID: 39277510 Free article.
Editorial: symptom improvement does not equal satisfaction with treatment for constipation-authors' reply.
Basilisco G, Barbara G, Bellini M, Cataudella G, D'Alba L, Guarino M, Iovino P, Neri MC, Sarnelli G, Savarino E, Tolone S, Torresan F, Usai-Satta P, Lovati A, Arsiè E, Coletta M. Basilisco G, et al. Among authors: coletta m. Aliment Pharmacol Ther. 2020 May;51(9):910-911. doi: 10.1111/apt.15697. Aliment Pharmacol Ther. 2020. PMID: 32285509 No abstract available.
Effectiveness of Third-Class Biologic Treatment in Crohn's Disease: A Multi-Center Retrospective Cohort Study.
Albshesh A, Taylor J, Savarino EV, Truyens M, Armuzzi A, Ribaldone DG, Shitrit AB, Fibelman M, Molander P, Liefferinckx C, Nancey S, Korani M, Rutka M, Barreiro-de Acosta M, Domislovic V, Suris G, Eriksson C, Alves C, Mpitouli A, di Jiang C, Tepeš K, Coletta M, Foteinogiannopoulou K, Gisbert JP, Amir-Barak H, Attauabi M, Seidelin J, Afif W, Marinelli C, Lobaton T, Pugliese D, Maharshak N, Cremer A, Limdi JK, Molnár T, Otero-Alvarin B, Krznaric Z, Magro F, Karmiris K, Raine T, Drobne D, Koutroubakis I, Chaparro M, Yanai H, Burisch J, Kopylov U. Albshesh A, et al. Among authors: coletta m. J Clin Med. 2021 Jun 29;10(13):2914. doi: 10.3390/jcm10132914. J Clin Med. 2021. PMID: 34209880 Free PMC article.
Corrigendum to: Immunological Variables Associated With Clinical and Endoscopic Response to Vedolizumab in Patients With Inflammatory Bowel Diseases.
Coletta M, Paroni M, Alvisi MF, De Luca M, Rulli E, Mazza S, Facciotti F, Lattanzi G, Strati F, Abrignani S, Claudio Fantini M, Vecchi M, Geginat J, Caprioli F. Coletta M, et al. J Crohns Colitis. 2022 Jul 14;16(6):1010. doi: 10.1093/ecco-jcc/jjab107. J Crohns Colitis. 2022. PMID: 34850867 No abstract available.
Effectiveness and safety of vedolizumab in a matched cohort of elderly and nonelderly patients with inflammatory bowel disease: the IG-IBD LIVE study.
Pugliese D, Privitera G, Crispino F, Mezzina N, Castiglione F, Fiorino G, Laterza L, Viola A, Bertani L, Caprioli F, Cappello M, Barberio B, Ricci C, Balestrieri P, Daperno M, Pluchino D, Rizzello F, Scribano ML, Sablich R, Pastorelli L, Manguso F, Variola A, Di Sario A, Grossi L, Armuzzi A; IG‐IBD LIVE Study Group. Pugliese D, et al. Aliment Pharmacol Ther. 2022 Jul;56(1):95-109. doi: 10.1111/apt.16923. Epub 2022 May 12. Aliment Pharmacol Ther. 2022. PMID: 35876062 Free PMC article.
467 results